Iradimed Q2 revenue flat at $20.5M, EPS down; declares $0.20 dividend; reaffirms FY guidance

IRADIMED CORP

Q2 revenue $20.5M (+0.5% YoY); GAAP EPS $0.41 (down from $0.45); non-GAAP EPS $0.46 (down from $0.49).
Declared quarterly cash dividend of $0.20 per share, payable Aug 28, 2026 to holders of record Aug 14.
Reaffirmed FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP EPS $2.09-2.24.
Launched next-gen 3870 MR IV pump; initial shipments met plan; domestic monitor unit bookings set record.
Q3 2026 guidance: revenue $23-24.5M, GAAP EPS $0.49-0.54, non-GAAP EPS $0.54-0.59.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.